213598-11-9

Basic information

• Product Name: METHYL 3-CYANO-4-ISOPROPOXYBENZOATE
• Synonyms: METHYL 3-CYANO-4-ISOPROPOXYBENZOATE;Methyl 3-cyano-4-[(1-Methylethyl)oxy]benzoate;methyl 3-cyano-4-propan-2-yloxybenzoate
• CAS NO: 213598-11-9
• Molecular Formula: C₁₂H₁₃NO₃
• Molecular Weight: 219.24
• Mol File: 213598-11-9.mol
• Article Data: 15

Chemical Properties

• Boiling Point: 356.6±27.0 °C(Predicted)
• Appearance: /
• Density: 1.14±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• CAS DataBase Reference: METHYL 3-CYANO-4-ISOPROPOXYBENZOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 3-CYANO-4-ISOPROPOXYBENZOATE(213598-11-9)
• EPA Substance Registry System: METHYL 3-CYANO-4-ISOPROPOXYBENZOATE(213598-11-9)

Safety Data

• Hazardous Substances Data: 213598-11-9(Hazardous Substances Data)

Usage

General Description

Methyl 3-cyano-4-isopropoxybenzoate is a chemical compound commonly used in the pharmaceutical and agricultural industries. It is a pale yellow liquid with a molecular formula of C12H13NO3 and a molecular weight of 219.24 g/mol. METHYL 3-CYANO-4-ISOPROPOXYBENZOATE has been found to have pesticidal properties, making it a popular ingredient in the production of insecticides and fungicides. Additionally, it is also used as a building block in the synthesis of various pharmaceutical drugs, particularly those used to treat pain and inflammation. However, as with any chemical compound, proper handling and storage are necessary to ensure safety and prevent harm to human health and the environment.

Upstream product

• 190271-78-4 methyl 3-formyl-4-isopropoxy-benzoate 
• 35826-59-6 methyl 4-isopropoxybenzoate 
• 24589-99-9 methyl 3-formyl-4-hydroxybenzoate 
• 75-30-9 2-iodo-propane 
• 773837-37-9 sodium cyanide 
• 15126-06-4 methyl 3-iodo-4-hydroxybenzoate 
• 258273-31-3 3-cyano-4-isopropoxybenzoic acid 
• 67-56-1 methanol 
• 75-26-3 isopropyl bromide 
• 156001-68-2 methyl 3-cyano-4-hydroxybenzoate 
• 213598-10-8 methyl 3-bromo-4-isopropoxybenzoate 
• 557-21-1 dicyanozinc 
• 29415-97-2 methyl 3-bromo-4-hydroxybenzoate 
• 14348-41-5 3-bromo-4-hydroxy-benzoic acid 

Downstream Products

• 258273-31-3 3-cyano-4-isopropoxybenzoic acid 
• 1306760-86-0 5-(3-{(1S)-1-[(2-hydroxyethyl)amino]-2,3-dihydro-1H-inden-4-yl}-1,2,4-oxadiazol-5-yl)-2-[(propan-2-yl)oxy]benzonitrile 
• 1312035-13-4 4-[5-(5-{3-cyano-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-6-(methyloxy)-1H-indazol-1-yl]butanoic acid 
• 1312009-60-1 4-[5-(5-{3-cyano-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-6-ethyl-1H-indazol-1-yl]butanoic acid 
• 1312009-58-7 4-[5-(5-{3-cyano-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-6-methyl-1H-indazol-1-yl]butanoic acid 
• 1312009-57-6 4-[6-chloro-5-(5-{3-cyano-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-1H-indazol-1-yl]butanoic acid 
• 1312009-30-5 5-[3-(1H-indazol-4-yl)-1,2,4-oxadiazol-5-yl]-2-[(1-methylethyl)oxy]benzonitrile 
• 1312009-26-9 ethyl 4-[5-(5-{3-cyano-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-6-(methyloxy)-1H-indazol-1-yl]butanoate 
• 1312009-61-2 ethyl 4-[5-(5-{3-cyano-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-6-ethyl-1H-indazol-1-yl]butanoate 
• 1312009-23-6 ethyl 4-[5-(5-{3-cyano-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-6-methyl-1H-indazol-1-yl]butanoate 
• 1312009-22-5 ethyl 4-[6-chloro-5-(5-{3-cyano-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-1H-indazol-1-yl]butanoate 
• 1072947-68-2 5-[3-(1H-indazol-5-yl)-1,2,4-oxadiazol-5-yl]-2-[(1-methylethyl)oxy]benzonitrile 
• 1307812-65-2 5-(7-bromo-4,5-dihydronaphtho[1,2-c]isoxazol-3-yl)-2-isopropoxybenzonitrile 
• 1307812-77-6 ethyl 3-(3-(3-cyano-4-isopropoxyphenyl)-4,5-dihydronaphtho[1,2-c]isoxazol-7-yl)propanoate 

Relevant articles and documents

AMINO ALCOHOL DERIVATIVE, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF

The present invention belongs to the field of medicine, and specifically discloses an amino alcohol derivative represented by Formula I, a pharmaceutically acceptable salt, solvate, polymorph or prodrug thereof. In addition, the present invention also discloses a pharmaceutical composition comprising the above substances, and a use of the substance in the preparation of a medicament for the prevention and treatment of an immune inflammatory disease, or a disease or condition associated with immunological competence such as multiple sclerosis, ALS, CIDP, systemic lupus erythematosus, rheumatoid arthritis, ulcerative colitis, psoriasis, polymyositis, etc.

Method for preparing 3-cyano-4-isopropoxybenzoic acid

The invention discloses a method for preparing 3-cyano-4-isopropoxybenzoic acid. A first step, 3-formyl-4-methyl hydroxybenzoate is prepared with methyl parahydroxybenzoate; a second step, 3-cyano-4-methyl hydroxybenzoate is prepared with the 3-formyl-4-methyl hydroxybenzoate; a third step, 3-cyano-4-methyl isopropoxybenzoate is prepared with the 3-cyano-4-methyl hydroxybenzoate; a fourth step, the 3-cyano-4-isopropoxybenzoic acid is prepared with the 3-cyano-4-methyl isopropoxybenzoate. The preparation method of the 3-cyano-4-isopropoxybenzoic acid, which is provided by the invention, has the advantages that 1) the use of the cuprous cyanide of hypertoxic cyanide in a previous process is avoided, and the method is more suitable for industrialization; 2) cyano is prepared by formyl, and the method is high-efficiency and direct, and is suitable for quantity production; 3) all raw materials are cheap and easily obtained, and the cost advantage is obvious.

Preparation method of 3-cyano-4-isopropoxy methyl benzoate

The invention discloses a preparation method of 3-cyano-4-isopropoxy methyl benzoate. The preparation method comprises the following steps: step I, preparing 3-aldehyde-4-methyl hydroxybenzoate from methyl p-hydroxybenzoate; step II, preparing 3-cyano-4-m